Best Practice & Research Clinical Haematology

Papers
(The H4-Index of Best Practice & Research Clinical Haematology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Contemporary and future strategies in polycythemia vera69
The role of randomized controlled trials, registries, observational databases in evaluating new interventions27
Coagulopathy in COVID-19 and anticoagulation clinical trials25
HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation25
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALL22
Endpoint selection and evaluation in hematology studies22
“The state of the science” of childhood, adolescent and young adult Non Hodgkin Lymphoma (NHL)21
Allogeneic “Off-the-Shelf” CAR T cells: Challenges and advances19
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program19
Editorial Board19
Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes19
The presentation of results from studies in clinical haematology16
Take a spin: Apheresis in the care of adult leukaemia patients14
How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigms14
0.14094400405884